-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Ernexa Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2010 to Q3 2025.
- Ernexa Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 8.23M shares, a 2179% increase year-over-year.
- Ernexa Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 13.6M shares, a 157% increase from 2023.
- Ernexa Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 5.31M shares, a 74.2% increase from 2022.
- Ernexa Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3.05M shares, a 40.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)